Search research articles
Contact Us
Filters
Showing results (51-60 of 66) with videos related to
Page
of 7
Sort By:
Transplantation
|
January 12, 1999
Comparison of neoral dose monitoring with cyclosporine through levels versus 2-hr postdose levels in stable liver transplant patients
M Cantarovich, J S Barkun, J I Tchervenkov, et al.
Oncology
|
January 1, 1984
Pharmacokinetics of Lonidamine after oral administration in cancer patients
J G Besner, R Leclaire, P R Band, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
January 1, 1989
Determination of opiates and other basic drugs by high-performance liquid chromatography with electrochemical detection
J G Besner, C Band, J J Rondeau, et al.
Clinical Pharmacology and Therapeutics
|
March 31, 2000
Nonlinear kinetics and pharmacologic response to mibefradil
P du Souich, J G Besner, J P Clozel, et al.
Cancer Treatment Reports
|
March 1, 1985
Single-dose pharmacokinetic study of 13-cis-retinoic acid in man
J G Besner, R Leclaire, P Band, et al.
Journal of Clinical Pharmacology
|
August 1, 1997
Plasma levels of nicotine and safety of smokers wearing transdermal delivery systems during multiple simultaneous intake of nicotine and during exercise
W Homsy, K Yan, J M Houle, et al.
Cancer Treatment Reports
|
June 1, 1986
Phase II study of lonidamine in patients with metastatic renal cell carcinoma: a National Cancer Institute of Canada Clinical Trials Group Study
B H Weinerman, E A Eisenhauer, J G Besner, et al.
Journal of Chromatography
|
October 14, 1983
High-performance liquid chromatography of lonidamine in human plasma and urine
R Leclaire, J G Besner, P Band, et al.
Cancer Treatment Reports
|
September 1, 1982
Phase I study of 13-cis-retinoic acid toxicity
P R Band, J G Besner, R Leclaire, et al.
Transplantation Proceedings
|
June 24, 1998
Cyclosporine peak levels provide a better correlation with the area-under-the-curve than trough levels in liver transplant patients treated with neoral
M Cantarovich, J Barkun, J G Besner, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 66) with videos related to
Sort By:
Page
of 7
Transplantation
|
January 12, 1999
Comparison of neoral dose monitoring with cyclosporine through levels versus 2-hr postdose levels in stable liver transplant patients
M Cantarovich, J S Barkun, J I Tchervenkov, et al.
Oncology
|
January 1, 1984
Pharmacokinetics of Lonidamine after oral administration in cancer patients
J G Besner, R Leclaire, P R Band, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
January 1, 1989
Determination of opiates and other basic drugs by high-performance liquid chromatography with electrochemical detection
J G Besner, C Band, J J Rondeau, et al.
Clinical Pharmacology and Therapeutics
|
March 31, 2000
Nonlinear kinetics and pharmacologic response to mibefradil
P du Souich, J G Besner, J P Clozel, et al.
Cancer Treatment Reports
|
March 1, 1985
Single-dose pharmacokinetic study of 13-cis-retinoic acid in man
J G Besner, R Leclaire, P Band, et al.
Journal of Clinical Pharmacology
|
August 1, 1997
Plasma levels of nicotine and safety of smokers wearing transdermal delivery systems during multiple simultaneous intake of nicotine and during exercise
W Homsy, K Yan, J M Houle, et al.
Cancer Treatment Reports
|
June 1, 1986
Phase II study of lonidamine in patients with metastatic renal cell carcinoma: a National Cancer Institute of Canada Clinical Trials Group Study
B H Weinerman, E A Eisenhauer, J G Besner, et al.
Journal of Chromatography
|
October 14, 1983
High-performance liquid chromatography of lonidamine in human plasma and urine
R Leclaire, J G Besner, P Band, et al.
Cancer Treatment Reports
|
September 1, 1982
Phase I study of 13-cis-retinoic acid toxicity
P R Band, J G Besner, R Leclaire, et al.
Transplantation Proceedings
|
June 24, 1998
Cyclosporine peak levels provide a better correlation with the area-under-the-curve than trough levels in liver transplant patients treated with neoral
M Cantarovich, J Barkun, J G Besner, et al.
Page
of 7